The substance is in use throughout a few World Tour teams, but is equally criticized by others. For some, it is argued that it is a form of doping, however there are no limitations on it's use in the current situation. A move that may be seen as controversial by some, however one that the team feels is beneficial.
“deltaG is thrilled to announce a milestone partnership with
Alpecin-Deceuninck," the company's chief strategy officer Brian McMahon added. "This collaboration allows us to support an organization we believe is on a path to continued success, both in performance and reputation. We are excited to formalize this relationship and share the news with the world."